MEI Pharma Company Profile (NASDAQ:MEIP)

About MEI Pharma

MEI Pharma logoMEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the treatment of advanced hematologic diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ME-344 is an isoflavone-based mitochondrial inhibitor targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. PWT143 is an oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that plays a critical role in the proliferation and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase I and Phase II clinical trials in advanced hematologic malignancies and solid tumor indications.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MEIP
  • CUSIP:
Key Metrics:
  • Previous Close: $1.74
  • 50 Day Moving Average: $1.51
  • 200 Day Moving Average: $1.64
  • 52-Week Range: $36,772,000.00 - $1.07
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.25
  • P/E Growth: 860.00
  • Market Cap: $63.98M
  • Outstanding Shares: 36,772,000
  • Beta: 1.01
Profitability:
  • Return on Equity: -7.59%
  • Return on Assets: -6.49%
Debt:
  • Current Ratio: 17.42%
  • Quick Ratio: 17.42%
Additional Links:
Companies Related to MEI Pharma:

Analyst Ratings

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.00 (14.94% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)
Show:
DateFirmActionRatingPrice TargetDetails
8/2/2016WedbushReiterated RatingNeutral$2.00View Rating Details
10/7/2015Cowen and CompanyReiterated RatingBuyView Rating Details
9/2/2015Cantor FitzgeraldReiterated RatingBuyView Rating Details
3/24/2015Bank of America CorpDowngradeBuy -> NeutralView Rating Details
3/24/2015Wells Fargo & CompanyDowngradeOutperform -> Market Perform$2.25 -> $2.00View Rating Details
3/23/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
3/23/2015Roth CapitalDowngradeBuy -> Neutral$14.00 -> $2.50View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for MEI Pharma (NASDAQ:MEIP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2017        
2/8/2017Q217($0.29)$0.32$17.10 millionViewN/AView Earnings Details
9/2/2015($0.23)($0.17)ViewN/AView Earnings Details
9/10/2014($0.37)($0.40)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MEI Pharma (NASDAQ:MEIP)
Current Year EPS Consensus Estimate: $-0.02 EPS
Next Year EPS Consensus Estimate: $-1.39 EPS

Dividends

Dividend History for MEI Pharma (NASDAQ:MEIP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MEI Pharma (NASDAQ:MEIP)
Insider Ownership Percentage: 4.62%
Institutional Ownership Percentage: 15.01%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2015Vivo Ventures Vii, LlcMajor ShareholderSell390,572$1.84$718,652.48View SEC Filing  
1/21/2015Charles V Baltic IIIDirectorBuy5,000$3.81$19,050.00View SEC Filing  
12/9/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell79,085$6.01$475,300.85View SEC Filing  
12/8/2014Leaf Ventures Ii L.P. NewMajor ShareholderSell9,004$6.05$54,474.20View SEC Filing  
6/30/2014Charles V Baltic IIIDirectorBuy2,000$6.56$13,120.00View SEC Filing  
10/29/2013Vivo Ventures Vii, LlcMajor ShareholderSell299,609$8.21$2,459,789.89View SEC Filing  
10/2/2013Vivo Ventures Vii, LlcMajor ShareholderSell581,646$10.16$5,909,523.36View SEC Filing  
8/16/2013Charles V Baltic IIIDirectorBuy2,600$6.82$17,732.00View SEC Filing  
6/28/2013Vivo Ventures Vii, LlcMajor ShareholderSell7,337$7.58$55,614.46View SEC Filing  
6/11/2013Vivo Ventures V, LlcMajor ShareholderSell13,727$7.80$107,070.60View SEC Filing  
5/16/2013Vivo Ventures Vii, LlcMajor ShareholderSell17,428$9.07$158,071.96View SEC Filing  
5/8/2013Leaf Ventures Ii L.P. NewMajor ShareholderSell200,000$8.58$1,716,000.00View SEC Filing  
1/25/2013Charles V Baltic IIIDirectorBuy10,200$6.04$61,608.00View SEC Filing  
12/21/2012Charles V Baltic IIIDirectorBuy3,500$7.18$25,130.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MEI Pharma (NASDAQ:MEIP)
DateHeadline
investornewswire.com logoSentiments And Ratings Alert: MEI Pharma, Inc. (NASDAQ:MEIP) - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - February 20 at 10:09 AM
News IconMEI Pharma, Inc. (MEIP) Under Analyst Spotlight - UK Market News (NASDAQ:MEIP)
www.ukmarketnews.co.uk - February 17 at 2:34 PM
News IconTrading Desk: What are the Numbers Saying About MEI Pharma, Inc. (NASDAQ:MEIP) - Piedmont Register (NASDAQ:MEIP)
piedmontregister.com - February 17 at 2:34 PM
News IconMA Watch on Shares of MEI Pharma Inc. (MEIP) - Rives Journal (NASDAQ:MEIP)
rivesjournal.com - February 14 at 5:41 AM
finance.yahoo.com logoMEI PHARMA, INC. Financials (NASDAQ:MEIP)
finance.yahoo.com - February 11 at 6:36 PM
bizjournals.com logoMEI Pharma Reports Second Quarter Fiscal Year 2017 Results (NASDAQ:MEIP)
www.bizjournals.com - February 8 at 7:18 PM
biz.yahoo.com logoMEI PHARMA, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:MEIP)
biz.yahoo.com - February 8 at 7:18 PM
News IconMarket Focus: Checking in on Shares of MEI Pharma Inc. (MEIP) - Rives Journal (NASDAQ:MEIP)
rivesjournal.com - February 8 at 12:49 AM
investornewswire.com logoEPS Projection For MEI Pharma, Inc. (NASDAQ:MEIP) Set At $-0.52 - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - February 4 at 5:13 AM
News IconTicker Watch: Technical Views on Shares of MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - February 4 at 5:13 AM
News IconTechnical Study: Following Indicators for MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - February 2 at 5:23 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at MEI Pharma, Inc. (NASDAQ:MEIP) - Nelson Research (NASDAQ:MEIP)
nelsonobserver.com - February 2 at 12:21 AM
News IconOn the Hunt For the Next Wonder Stock: Penny Stock MEI Pharma, Inc. (NASDAQ:MEIP) - Nelson Research (NASDAQ:MEIP)
nelsonobserver.com - February 1 at 7:20 PM
News IconEarnings Parade Rolls On, What Are Analysts Saying About MEI Pharma, Inc. (NASDAQ:MEIP)? - Wall Street Beacon (NASDAQ:MEIP)
wsbeacon.com - February 1 at 7:20 PM
News IconADX Watch on Shares of MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - January 28 at 5:03 AM
News IconEarnings in Full Force, Analysts Take Aim at MEI Pharma, Inc. (NASDAQ:MEIP) - Wall Street Beacon (NASDAQ:MEIP)
wsbeacon.com - January 26 at 9:23 PM
realistinvestor.com logoEPS Projection Of MEI Pharma, Inc. (NASDAQ:MEIP) At $-0.52 - RealistInvestor.com (NASDAQ:MEIP)
www.realistinvestor.com - January 26 at 9:23 PM
News IconMarket Rover: Looking at Levels on Shares of MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - January 26 at 9:23 PM
News IconWhat is the Street Saying About MEI Pharma, Inc. (NASDAQ:MEIP)? - Aiken Advocate (NASDAQ:MEIP)
aikenadvocate.com - January 26 at 9:23 PM
News IconMA Watch on Shares of MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - January 23 at 6:49 PM
News IconMEI Pharma, Inc. (NASDAQ:MEIP) Projected EPS At $-0.21 - Stock Observer (NASDAQ:MEIP)
www.thestockobserver.com - January 23 at 6:49 PM
News IconTrump Sworn In as S&P Declined, How Did this Stock Perform This Week: MEI Pharma, Inc. (NASDAQ:MEIP) - Aiken Advocate (NASDAQ:MEIP)
aikenadvocate.com - January 22 at 4:25 AM
News IconMoving Averages in Focus on Shares of MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - January 19 at 8:32 PM
News IconStock Perspective: MEI Pharma, Inc. (NASDAQ:MEIP) Company Earnings Watch - Aiken Advocate (NASDAQ:MEIP)
aikenadvocate.com - January 19 at 8:32 PM
News IconAre Cagey Traders Interested in These Shares: MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 19 at 8:32 PM
News IconCheck on Average Directional Index for MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - January 19 at 5:02 AM
News IconWhich Direction is This Stock Headed? Update on MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 19 at 5:02 AM
investornewswire.com logoMEI Pharma, Inc. (NASDAQ:MEIP) Strong Sell Recommendations At 0 - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - January 17 at 11:51 PM
News IconActive Trading Watch on Shares of MEI Pharma Inc. (MEIP) - Sherwood Daily (NASDAQ:MEIP)
sherwooddaily.com - January 17 at 11:51 PM
News IconInvestors Swarm in on MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 17 at 11:51 PM
News IconMEI Pharma, Inc. (NASDAQ:MEIP) Projected to Achieve EPS Of ... - Stock Observer (NASDAQ:MEIP)
www.thestockobserver.com - January 17 at 11:50 AM
News IconWill The Needle Move For MEI Pharma, Inc. (NASDAQ:MEIP) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:MEIP)
wsbeacon.com - January 17 at 11:50 AM
News IconCheap Stock Alert & Update on MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 14 at 5:49 AM
investornewswire.com logoMEI Pharma, Inc. (NASDAQ:MEIP) Records An Impact Score Of 33 - Investor Newswire (NASDAQ:MEIP)
www.investornewswire.com - January 12 at 7:01 PM
News IconIs This a Sensible Stock at Current Levels: MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 12 at 7:00 PM
News IconInvestors Keen on a Bargain are Looking at MEI Pharma, Inc ... - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 12 at 12:06 AM
realistinvestor.com logoMEI Pharma, Inc. (NASDAQ:MEIP) EPS Estimate At $-0.52 - RealistInvestor.com (NASDAQ:MEIP)
www.realistinvestor.com - January 12 at 12:06 AM
News IconUnder the Microscope We Place Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 10 at 7:24 PM
News IconCan This Stock Grab Upward Traction: MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - January 10 at 6:58 AM
News IconMEI Pharma Inc MEIP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:MEIP)
www.bioportfolio.com - January 6 at 7:12 PM
realistinvestor.com logoMEI Pharma, Inc. (NASDAQ:MEIP) Is Expected To Post EPS Of $-0.52 - RealistInvestor.com (NASDAQ:MEIP)
www.realistinvestor.com - January 6 at 5:57 AM
News IconStock ABR Of MEI Pharma, Inc. (NASDAQ:MEIP) At 3 - Stock Observer (NASDAQ:MEIP)
www.thestockobserver.com - January 6 at 5:57 AM
realistinvestor.com logoMEI Pharma, Inc. (NASDAQ:MEIP) EPS Estimaged At $-0.52 - RealistInvestor.com (NASDAQ:MEIP)
www.realistinvestor.com - December 30 at 6:53 PM
News IconMEI Pharma, Inc. (MEIP) Valuation According To Analysts - UK ... - UK Market News (NASDAQ:MEIP)
www.ukmarketnews.co.uk - December 30 at 6:53 PM
News IconPeering into Recent Action from MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - December 30 at 6:53 PM
News IconHoning in on Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - December 27 at 6:25 PM
News IconAstute Investors Are Taking a Look at MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - December 22 at 6:49 PM
News IconInside the Numbers on Shares of MEI Pharma, Inc. (NASDAQ:MEIP) - Liberty News (NASDAQ:MEIP)
libertynewsrecord.com - December 22 at 5:24 AM
News IconCan This Stock Make a Ripple in the Market: MEI Pharma, Inc. (NASDAQ:MEIP) - Prospect Journal (NASDAQ:MEIP)
prospectjournal.com - December 21 at 7:22 PM
News IconInside the Numbers on Shares of MEI Pharma, Inc. (NASDAQ:MEIP ... - Liberty News (NASDAQ:MEIP)
libertynewsrecord.com - December 21 at 7:22 PM

Social

What is MEI Pharma's stock symbol?

MEI Pharma trades on the NASDAQ under the ticker symbol "MEIP."

Where is MEI Pharma's stock going? Where will MEI Pharma's stock price be in 2017?

1 brokers have issued 12-month target prices for MEI Pharma's shares. Their predictions range from $2.00 to $2.00. On average, they expect MEI Pharma's stock price to reach $2.00 in the next twelve months.

When will MEI Pharma announce their earnings?

MEI Pharma is scheduled to release their next quarterly earnings announcement on Wednesday, February, 8th 2017.

Who owns MEI Pharma stock?

MEI Pharma's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.68%), Interwest Venture Management Co. (1.58%), Ancora Advisors LLC (0.88%) and FMR LLC (0.86%).

Who sold MEI Pharma stock? Who is selling MEI Pharma stock?

MEI Pharma's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Ancora Advisors LLC.

Who bought MEI Pharma stock? Who is buying MEI Pharma stock?

MEI Pharma's stock was bought by a variety of institutional investors in the last quarter, including Interwest Venture Management Co. and FMR LLC.

How do I buy MEI Pharma stock?

Shares of MEI Pharma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of MEI Pharma stock cost?

One share of MEI Pharma stock can currently be purchased for approximately $1.74.

MEI Pharma (NASDAQ:MEIP) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for MEI Pharma (NASDAQ:MEIP)

Earnings History Chart

Earnings by Quarter for MEI Pharma (NASDAQ:MEIP)

Dividend History Chart

Dividend Payments by Quarter for MEI Pharma (NASDAQ:MEIP)

Last Updated on 2/20/2017 by MarketBeat.com Staff